BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25622261)

  • 1. The influence of AHI1 variants on the diagnosis and treatment outcome in schizophrenia.
    Porcelli S; Pae CU; Han C; Lee SJ; Patkar AA; Masand PS; Balzarro B; Alberti S; De Ronchi D; Serretti A
    Int J Mol Sci; 2015 Jan; 16(2):2517-29. PubMed ID: 25622261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study.
    Rivero O; Reif A; Sanjuán J; Moltó MD; Kittel-Schneider S; Nájera C; Töpner T; Lesch KP
    PLoS One; 2010 Aug; 5(8):e12254. PubMed ID: 20805890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics.
    Crisafulli C; Chiesa A; Han C; Lee SJ; Park MH; Balzarro B; Andrisano C; Patkar AA; Pae CU; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2012 Apr; 262(3):199-205. PubMed ID: 22120873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abelson helper integration site-1 gene variants on major depressive disorder and bipolar disorder.
    Porcelli S; Pae CU; Han C; Lee SJ; Patkar AA; Masand PS; Balzarro B; Alberti S; De Ronchi D; Serretti A
    Psychiatry Investig; 2014 Oct; 11(4):481-6. PubMed ID: 25395981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.
    Calabrò M; Porcelli S; Crisafulli C; Wang SM; Lee SJ; Han C; Patkar AA; Masand PS; Albani D; Raimondi I; Forloni G; Bin S; Mattiaccio A; Mantovani V; Jun TY; Pae CU; Serretti A
    Adv Ther; 2017 Jun; 34(6):1482-1497. PubMed ID: 28508933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia.
    Crisafulli C; Chiesa A; Han C; Lee SJ; Shim DS; Balzarro B; Andrisano C; Sidoti A; Patkar AA; Pae CU; Serretti A
    Neurosci Lett; 2012 Feb; 508(1):37-41. PubMed ID: 22198373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes.
    Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Serretti A
    Int J Psychiatry Clin Pract; 2011 Nov; 15(4):303-10. PubMed ID: 22122005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.
    Crisafulli C; Chiesa A; De Ronchi D; Han C; Lee SJ; Park MH; Patkar AA; Pae CU; Serretti A
    Neurosci Lett; 2012 Jan; 506(1):170-4. PubMed ID: 22094384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.
    Calabrò M; Porcelli S; Crisafulli C; Wang SM; Lee SJ; Han C; Patkar AA; Masand PS; Albani D; Raimondi I; Forloni G; Bin S; Cristalli C; Mantovani V; Pae CU; Serretti A
    J Mol Neurosci; 2018 Jan; 64(1):62-74. PubMed ID: 29164477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder.
    Slonimsky A; Levy I; Kohn Y; Rigbi A; Ben-Asher E; Lancet D; Agam G; Lerer B
    Schizophr Res; 2010 Jul; 120(1-3):159-66. PubMed ID: 20452750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE7B, NMBR and EPM2A Variants and Schizophrenia: A Case-Control and Pharmacogenetics Study.
    Porcelli S; Balzarro B; Lee SJ; Han C; Patkar AA; Pae CU; Serretti A
    Neuropsychobiology; 2016; 73(3):160-8. PubMed ID: 27092952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.
    Schuhmacher A; Becker T; Rujescu D; Quednow BB; Lennertz L; Wagner M; Benninghoff J; Rietschel M; Häfner H; Franke P; Wölwer W; Gaebel W; Maier W; Mössner R
    J Psychiatr Res; 2012 Aug; 46(8):1073-80. PubMed ID: 22655589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association between 5'-upstream single-nucleotide polymorphisms of PDGFRB and schizophrenia in a Korean population.
    Kim HJ; Kim MH; Choe BK; Kim JW; Park JK; Cho AR; Bae H; Shin DH; Yim SV; Kwack K; Kwon YK; Chung JH
    Schizophr Res; 2008 Aug; 103(1-3):201-8. PubMed ID: 18541413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil.
    Cordeiro Q; Talkowski ME; Chowdari KV; Wood J; Nimgaonkar V; Vallada H
    Genes Brain Behav; 2005 Feb; 4(1):45-50. PubMed ID: 15660667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of DISC1 genetic variants with the risk of schizophrenia.
    Luo X; Jin C; Zhou Z; Zhang F; Yuan J; Liu X; Cheng Z
    Psychiatr Genet; 2016 Jun; 26(3):132-5. PubMed ID: 26945459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients.
    Yang Y; Li W; Zhao J; Zhang H; Song X; Xiao B; Yang G; Jiang C; Zhang D; Yue W; Lv L
    Behav Brain Funct; 2012 Feb; 8():11. PubMed ID: 22369141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia.
    Amann-Zalcenstein D; Avidan N; Kanyas K; Ebstein RP; Kohn Y; Hamdan A; Ben-Asher E; Karni O; Mujaheed M; Segman RH; Maier W; Macciardi F; Beckmann JS; Lancet D; Lerer B
    Eur J Hum Genet; 2006 Oct; 14(10):1111-9. PubMed ID: 16773125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible association between the gamma-aminobutyric acid type B receptor 1 (GABBR1) gene and schizophrenia.
    Zai G; King N; Wong GW; Barr CL; Kennedy JL
    Eur Neuropsychopharmacol; 2005 May; 15(3):347-52. PubMed ID: 15820424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study.
    Porcelli S; Lee SJ; Han C; Patkar AA; Serretti A; Pae CU
    Psychiatr Genet; 2015 Aug; 25(4):163-7. PubMed ID: 26049408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.